These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9218635)

  • 1. Possible involvement of G-proteins in the regulation of striatal dopamine D2 receptor affinity by cholecystokinin octapeptide.
    Li XM; Jansson A; Finnman UB; Agnati LF; Fuxe K
    Neurosci Lett; 1997 Jun; 228(3):171-4. PubMed ID: 9218635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes.
    Li XM; Hedlund PB; Agnati LF; Fuxe K
    Brain Res; 1994 Jul; 650(2):289-98. PubMed ID: 7953694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections.
    Li XM; Hedlund PB; Fuxe K
    Eur J Neurosci; 1995 May; 7(5):962-71. PubMed ID: 7613631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.
    Tanganelli S; Li XM; Ferraro L; Von Euler G; O'Connor WT; Bianchi C; Beani L; Fuxe K
    Eur J Pharmacol; 1993 Jan; 230(2):159-66. PubMed ID: 8422898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes.
    Ferré S; Snaprud P; Fuxe K
    Eur J Pharmacol; 1993 Feb; 244(3):311-5. PubMed ID: 8458403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin receptor subtypes regulate dopamine D2 receptors in rat neostriatal membranes. Involvement of D1 receptors.
    Li XM; Hedlund PB; Fuxe K
    Ann N Y Acad Sci; 1994 Mar; 713():386-7. PubMed ID: 7910442
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
    Florijn WJ; De Boer T; Tonnaer JA; Versteeg DH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):787-92. PubMed ID: 1331413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra.
    Li XM; Zoli M; Finnman UB; Le Novère N; Changeux JP; Fuxe K
    Brain Res; 1995 May; 679(1):157-67. PubMed ID: 7648259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs.
    Dasgupta S; Li XM; Jansson A; Finnman UB; Matsui T; Rinken A; Arenas E; Agnati LF; Fuxe K
    Brain Res Mol Brain Res; 1996 Mar; 36(2):292-9. PubMed ID: 8965650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
    Inoue A; Miki S; Seto M; Kikuchi T; Morita S; Ueda H; Misu Y; Nakata Y
    Eur J Pharmacol; 1997 Feb; 321(1):105-11. PubMed ID: 9083792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
    Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK; Robertson RG
    Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.
    Nickolls SA; Strange PG
    Biochem Pharmacol; 2003 Apr; 65(7):1139-50. PubMed ID: 12663049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.
    Geurts M; Hermans E; Maloteaux JM
    Life Sci; 1999; 65(16):1633-45. PubMed ID: 10573181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.
    Minuzzi L; Cumming P
    Neurochem Int; 2010; 56(6-7):747-52. PubMed ID: 20117160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin [corrected] octapeptide modulates dopamine release in rat striatum.
    Rakovska A
    Neurosci Lett; 1995 Aug; 195(3):151-4. PubMed ID: 8584197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism.
    von Euler G; van der Ploeg I; Fredholm BB; Fuxe K
    J Neurochem; 1991 Jan; 56(1):178-83. PubMed ID: 1824779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum.
    Hamdi A
    Life Sci; 1998; 63(23):2115-20. PubMed ID: 9839535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.